Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Ionis’ HAE Opportunity Boosted By Positive Phase II Data
Wholly Owned PKK-LRx HAE Candidate Hit All Endpoints
Mar 30 2021
•
By
Sten Stovall
Positive HAE data lifts investor sentiment towards Ionis stock • Source: Shutterstock
More from Clinical Trials
More from R&D